Cyclooxygenase-2 expression in early gastric cancer, intestinal metaplasia and Helicobacter pylori infection

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 4, 2002, Pages 347-349

  Walker, Marjorie M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

COX 2; Cyclooxygenases; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

APC PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

CANCER RISK; CHEMOPROPHYLAXIS; COLON CANCER; ENZYME INDUCTION; GENE OVEREXPRESSION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; INFLAMMATION; INTESTINE METAPLASIA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; STOMACH CANCER; STOMACH MUCOSA;

CYCLOOXYGENASE 2; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS;

EID: 0036229209     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200204000-00001     Document Type: Short Survey

References (21)

1. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia
2. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
3. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: Controversial issues and perspectives
4. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer
5. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study
6. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
7. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
8. Precancerous lesions in two counties of China with contrasting gastric cancer risk
9. Chronic immune activation and inflammation as the cause of malignancy
10. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts
11. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori
12. Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice
13. Atrophy, metaplasia and dysplasia: Are they reversible?
14. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
15. Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication
16. Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan
17. Influence of gastric pH modifiers on development of intestinal metaplasia induced by X-irradiation in rats
18. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori
19. Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication
20. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
21. Potential adverse effects of cyclooxygenase-2 inhibition: Evidence from animal models of inflammation